Cel-Sci(DE:LSR)
€1.13-0.11 (-4.24%)
DE:LSR
Cel-Sci financials statements
€1.13
At close:-0.11 (-4.24%)
Cel-Sci (LSR) Ratios
0 Followers
Cel-Sci Ratios
DE:LSR's free cash flow for Q3 2026 was $-4.03M. For the 2026 fiscal year, DE:LSR's free cash flow was decreased by $-4.00 and operating cash flow was $-4.03M. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.26 | 1.31 | 1.24 | 5.45 | 11.50 |
| Quick Ratio | 2.20 | 1.09 | 0.84 | 5.02 | 10.99 |
| Cash Ratio | 2.13 | 1.03 | 0.74 | 4.86 | 9.16 |
| Solvency Ratio | -1.76 | -1.62 | -1.64 | -1.87 | -2.00 |
| Operating Cash Flow Ratio | -3.34 | -4.08 | -4.09 | -3.91 | -4.77 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -602.53K | $ -8.07M | $ -10.39M | $ 7.08M | $ 25.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.33 | 0.43 | 0.44 | 0.30 | 0.21 |
| Debt-to-Equity Ratio | 0.59 | 0.90 | 1.03 | 0.48 | 0.28 |
| Debt-to-Capital Ratio | 0.37 | 0.47 | 0.51 | 0.32 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.76 | 2.10 | 2.31 | 1.57 | 1.34 |
| Debt Service Coverage Ratio | -32.17 | -29.78 | -40.81 | -30.81 | -32.66 |
| Interest Coverage Ratio | -38.23 | -35.34 | -46.60 | -33.36 | -31.49 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.47 | 6.22 | 9.61 | 11.39 | 12.63 |
| Net Debt to EBITDA | 0.08 | -0.31 | -0.34 | 0.23 | 0.58 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.53% | 104.27% | 107.77% |
| EBT Per EBIT | 102.42% | 102.16% | 102.28% | 101.77% | 100.46% |
| Return on Assets (ROA) | -90.25% | -99.74% | -106.02% | -75.74% | -51.65% |
| Return on Equity (ROE) | -159.25% | -209.22% | -244.92% | -118.98% | -69.32% |
| Return on Capital Employed (ROCE) | -107.75% | -117.77% | -126.20% | -78.64% | -50.32% |
| Return on Invested Capital (ROIC) | -97.42% | -107.06% | -116.96% | -75.78% | -49.83% |
| Return on Tangible Assets | -90.64% | -100.35% | -106.71% | -76.06% | -51.84% |
| Earnings Yield | -68.10% | -35.47% | -48.51% | -23.92% | -7.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 14.97 | 2.74 | 1.97 | 2.40 | 0.30 |
| Inventory Turnover | 52.38 | 3.89 | 1.76 | 1.94 | 0.25 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -17.42 | -39.41 | 21.97 | 36.04 | 241.95 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 6.97 | 93.79 | 207.30 | 188.14 | 1467.74 |
| Days of Payables Outstanding | 24.38 | 133.20 | 185.32 | 152.10 | 1225.80 |
| Operating Cycle | 6.97 | 93.79 | 207.30 | 188.14 | 1467.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.22 | -9.46 | -15.41 | -12.68 | -13.86 |
| Free Cash Flow Per Share | -4.23 | -9.51 | -15.66 | -13.14 | -20.53 |
| Dividend Paid and CapEx Coverage Ratio | -449.23 | -198.27 | -61.38 | -27.61 | -2.08 |
| Capital Expenditure Coverage Ratio | -449.23 | -198.27 | -61.38 | -27.61 | -2.08 |
| Operating Cash Flow Coverage Ratio | -1.82 | -1.62 | -1.68 | -1.19 | -1.18 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -45.98% | -24.91% | -34.80% | -11.81% | -5.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.47 | -2.82 | -2.06 | -4.18 | -13.68 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.34 | 5.90 | 5.05 | 4.97 | 9.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.17 | -4.01 | -2.87 | -8.46 | -19.27 |
| Price-to-Operating Cash Flow Ratio | -2.18 | -4.03 | -2.92 | -8.77 | -28.54 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.07 | 0.11 | 0.57 | -1.51 |
| Enterprise Value Multiple | -1.71 | -3.73 | -2.76 | -4.81 | -14.87 |
| Enterprise Value | 35.74M | 82.77M | 76.15M | 152.63M | 516.16M |
| EV to EBITDA | -1.71 | -3.73 | -2.76 | -4.81 | -14.87 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.08 | -4.38 | -3.28 | -8.07 | -18.55 |
| EV to Operating Cash Flow | -2.09 | -4.40 | -3.33 | -8.37 | -27.47 |
| Tangible Book Value Per Share | 3.90 | 6.39 | 8.78 | 22.21 | 41.51 |
| Shareholders’ Equity Per Share | 3.93 | 6.47 | 8.91 | 22.36 | 41.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.04 | -0.08 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -6.27 | -13.54 | -21.83 | -26.61 | -28.91 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 1.04 | 1.08 |
| Interest Burden | 1.03 | 1.03 | 1.02 | 1.03 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.67 | 0.70 | 0.71 | 0.50 | 0.52 |
Currency in USD
